Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biocept Inc (BIOC)
NASDAQ:BIOC
Holding BIOC?
Track your performance easily
BIOC Stock Chart & Stats
Day’s Range$0.4 - $0.49
52-Week Range― - ―
Previous Close$0.5
Volume751.45K
Average Volume (3M)N/A
Market Cap
$1.14M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Nov 15, 2023EPS Estimate
-$2.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
Biocept News
Ownership Overview
0.00%
Insiders
0.00% Mutual Funds
1.71% Other Institutional Investors
98.29% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
BIOC FAQ
What was Biocept Inc’s price range in the past 12 months?
Currently, no data Available
What is Biocept Inc’s market cap?
Currently, no data Available
When is Biocept Inc’s upcoming earnings report date?
Biocept Inc’s upcoming earnings report date is Nov 15, 2023 which is 356 days ago.
How were Biocept Inc’s earnings last quarter?
Biocept Inc released its earnings results on Aug 14, 2023. The company reported -$3.5 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.5.
Is Biocept Inc overvalued?
According to Wall Street analysts Biocept Inc’s price is currently Overvalued.
Does Biocept Inc pay dividends?
Biocept Inc does not currently pay dividends.
What is Biocept Inc’s EPS estimate?
Biocept Inc’s EPS estimate is -$2.36.
How many shares outstanding does Biocept Inc have?
Currently, no data Available
What happened to Biocept Inc’s price movement after its last earnings report?
Biocept Inc reported an EPS of -$3.5 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.636%.
Which hedge fund is a major shareholder of Biocept Inc?
Among the largest hedge funds holding Biocept Inc’s share is Hussman Strategic Advisors Inc. It holds Biocept Inc’s shares valued at N/A.
---
Biocept Stock Smart Score
Company Description
Biocept Inc
Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.
---
BIOC Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---